US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ALVO

Alvontech (ALVO)

Alvontech

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALVO

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/14	06 : 05	GlobeNewswire Inc.	Alvotech Reports Financial Results for the First Nine Months of 2024	NASDAQ:ALVO	Alvontech
2024/11/07	22 : 00	GlobeNewswire Inc.	Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024	NASDAQ:ALVO	Alvontech
2024/11/04	21 : 00	GlobeNewswire Inc.	European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)	NASDAQ:ALVO	Alvontech
2024/10/30	21 : 30	GlobeNewswire Inc.	Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET	NASDAQ:ALVO	Alvontech
2024/10/25	21 : 00	GlobeNewswire Inc.	Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024	NASDAQ:ALVO	Alvontech
2024/10/22	20 : 00	GlobeNewswire Inc.	Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)	NASDAQ:ALVO	Alvontech
2024/10/10	18 : 00	GlobeNewswire Inc.	European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®	NASDAQ:ALVO	Alvontech
2024/09/25	18 : 00	GlobeNewswire Inc.	Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®	NASDAQ:ALVO	Alvontech
2024/08/26	22 : 14	GlobeNewswire Inc.	Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	NASDAQ:ALVO	Alvontech
2024/08/16	18 : 57	IH Market News	H&R Block Shares Surge 10% on Profit and Dividend Boost, Applied Materials Drops 3% Despite Strong Earnings, Latest in Earnings	NASDAQ:ALVO	Alvontech
2024/08/16	05 : 15	GlobeNewswire Inc.	Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024	NASDAQ:ALVO	Alvontech
2024/08/15	19 : 09	IH Market News	U.S. Futures Rise on Easing Inflation, Oil Prices Rise	NASDAQ:ALVO	Alvontech
2024/08/15	17 : 30	GlobeNewswire Inc.	European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)	NASDAQ:ALVO	Alvontech
2024/08/02	05 : 02	GlobeNewswire Inc.	Alvotech to Report Financial Results for the First Half of 2024 on August 15, 2024, and Host Conference Call on August 16, 2024, at 8:00 am ET	NASDAQ:ALVO	Alvontech
2024/07/22	19 : 30	GlobeNewswire Inc.	STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe	NASDAQ:ALVO	Alvontech
2024/07/11	17 : 45	GlobeNewswire Inc.	Alvotech Announces Closing of Private Debt Financing	NASDAQ:ALVO	Alvontech
2024/07/02	22 : 00	GlobeNewswire Inc.	Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Biosimilar for Prolia® and Xgeva®	NASDAQ:ALVO	Alvontech
2024/07/02	06 : 35	GlobeNewswire Inc.	Alvotech Issues New Shares to Holders of Convertible Bonds	NASDAQ:ALVO	Alvontech
2024/07/01	18 : 10	GlobeNewswire Inc.	Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the Second Quarter of 2024	NASDAQ:ALVO	Alvontech
2024/06/26	17 : 50	GlobeNewswire Inc.	Alvotech Receives Conversion Notices for Majority of Convertible Bonds	NASDAQ:ALVO	Alvontech
2024/06/18	17 : 01	GlobeNewswire Inc.	Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe	NASDAQ:ALVO	Alvontech
2024/06/11	17 : 00	GlobeNewswire Inc.	Alvotech and STADA add to strategic alliance through denosumab partnership	NASDAQ:ALVO	Alvontech
2024/06/07	17 : 00	GlobeNewswire Inc.	Alvotech Announces Strategic Refinancing Agreement	NASDAQ:ALVO	Alvontech
2024/05/29	21 : 05	GlobeNewswire Inc.	Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024	NASDAQ:ALVO	Alvontech
2024/05/22	06 : 15	GlobeNewswire Inc.	Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update	NASDAQ:ALVO	Alvontech
2024/05/21	23 : 05	Business Wire	Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK	NASDAQ:ALVO	Alvontech
2024/05/21	21 : 00	GlobeNewswire Inc.	Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK	NASDAQ:ALVO	Alvontech
2024/05/21	20 : 13	IH Market News	U.S. Index Futures Open Lower Amid Nasdaq Record, Fed Speeches	NASDAQ:ALVO	Alvontech
2024/05/21	09 : 25	Business Wire	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NASDAQ:ALVO	Alvontech
2024/05/21	09 : 25	GlobeNewswire Inc.	Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.	NASDAQ:ALVO	Alvontech

Showing the most relevant articles for your search:NASDAQ:ALVO

1 2 3 4 5 次へ >>

Invesco QQQ Trust Series 1

American Express

Financial Select Sector

US Dollar vs Euro

BNP Paribas (QX)

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約